Log In
Print
BCIQ
Print
Print this Print this
 

LPCN 1111

  Manage Alerts
Collapse Summary General Information
Company Lipocine Inc.
DescriptionOnce-daily oral formulation of testosterone using Lipocine's Lip'ral oral delivery technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationHypogonadism
Indication DetailsTreat hypogonadism
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today